June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
PAX6-positive microglia evolve locally in hiPSC-derived ocular organoids
Author Affiliations & Notes
  • Nobuhiko Shiraki
    Ophthalmology, Osaka Daigaku, Suita, Osaka, Japan
  • Kazuichi Maruyama
    Ophthalmology, Osaka Daigaku, Suita, Osaka, Japan
  • Ryuhei Hayashi
    Ophthalmology, Osaka Daigaku, Suita, Osaka, Japan
  • Susumu Sakimoto
    Ophthalmology, Osaka Daigaku, Suita, Osaka, Japan
  • Kohji Nishida
    Ophthalmology, Osaka Daigaku, Suita, Osaka, Japan
  • Footnotes
    Commercial Relationships   Nobuhiko Shiraki None; Kazuichi Maruyama None; Ryuhei Hayashi None; Susumu Sakimoto None; Kohji Nishida None
  • Footnotes
    Support   AMED Grant 20gm1210004, JSPS KAKENHI Grant JP17K11475
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 22. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nobuhiko Shiraki, Kazuichi Maruyama, Ryuhei Hayashi, Susumu Sakimoto, Kohji Nishida; PAX6-positive microglia evolve locally in hiPSC-derived ocular organoids. Invest. Ophthalmol. Vis. Sci. 2022;63(7):22.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Microglia are the resident immune cells of the central nervous system (CNS). Since the immune cells from the general circulation cannot reach the CNS due to the blood-brain barrier, the brain and spinal cord microglial cells provide immune protection for CNS. Also, the microglia provide immune protection to the posterior eye, including the neural retina, and are involved in some sight-threatening conditions, such as age-related macular degeneration, uveitis, glaucoma, and retinal degeneration. However, it is not known how the microglia develop in the eye.

Methods : We studied human-induced pluripotent stem cells (hiPSCs) that had been expanded into a self-formed ectodermal autonomous multi-zone (SEAM) (Hayashi et al. Nature 2016;531:376-380) of cells that partially mimicked the human eye development. We searched and investigated the microglia-like cells, sorted them, and examined them by quantitative polymerase chain reaction (qPCR), cytokine analysis, RNA sequencing (seq), and single-cell RNA seq.

Results : We discovered that they contained immune cells that were significantly similar to the microglia cells in SEAM. Moreover, the RNA-seq data and qPCR showed that the cells were more similar to primary microglia cells than to immortalized human microglia. The results of the functional stimulation assays revealed that the sorted cells are likely govern immune tolerance in the ocular tissue. Furthermore, single-cell RNA seq revealed that the cells resembled yolk sac-derived myeloid progenitors and not macrophages.

Conclusions : Our results showed that microglia-like cells showing characteristics of yolk sac-like linage cells naturally develop in SEAM organoids, which lack vascular components. These cells are unique because they are paired box protein 6 (PAX6)-positive, yet possess some characteristics of the mesoderm. Our data support the possibility of the existence of an isolated and locally developing immune system in the eye, which is independent of the body’s vasculature and general immune system.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

Schematic showing the expression pattern of microglia-related genes in the SEAM.

Schematic showing the expression pattern of microglia-related genes in the SEAM.

 

Immunostaining of TMEM119 (green) in zones 1-3 of a 4-week cultivated derived SEAM along with staining of PAX6 (red).

Immunostaining of TMEM119 (green) in zones 1-3 of a 4-week cultivated derived SEAM along with staining of PAX6 (red).

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×